{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:10:36Z","timestamp":1772827836680,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioelectrochemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bioelechem.2022.108196","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T19:45:30Z","timestamp":1656791130000},"page":"108196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Static or 50\u00a0Hz magnetic fields at 100 \u00b5T do not modify the clonogenic survival of doxorubicin-treated MCF-7 cancer cells"],"prefix":"10.1016","volume":"147","author":[{"given":"Valtteri","family":"Nieminen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miina","family":"Juntunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonne","family":"Naarala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Luukkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioelechem.2022.108196_b0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1109\/TEMC.2014.2359687","article-title":"Magnetic field exposure assessment in electric vehicles","volume":"57","author":"Vassilev","year":"2015","journal-title":"IEEE Trans. Electromagn. Compat."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bem.21817","article-title":"Occupational exposure levels of static magnetic field during routine MRI examination in 3T MR system","volume":"35","author":"Yamaguchi-Sekino","year":"2014","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/j.bioelechem.2022.108196_b0020","unstructured":"IARC, International Agency for Research on Cancer Iarc Monographs on the Evaluation of Carcinogenic Risks To Humans, Iarc Monogr. Eval. Carcinog. Risks To Humans Non-Ionizing Radiation, Part 1 Static Extrem. low-frequency Electr. Magn. fields, vol. 80, pp. i-ix+1-390, 2002."},{"key":"10.1016\/j.bioelechem.2022.108196_b0025","first-page":"1","article-title":"Environmental health criteria 238: Extremely low frequency fields","volume":"238","author":"Who","year":"2007","journal-title":"Environ. Heal. Criteria"},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0030","first-page":"83","article-title":"Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma","volume":"48","author":"Tofani","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09553000600577839","article-title":"Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies","volume":"82","author":"Juutilainen","year":"2006","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.bioelechem.2022.108196_b0040","doi-asserted-by":"crossref","unstructured":"J. Luukkonen, A. Liimatainen, A. H\u00f6yt\u00f6, J. Juutilainen, J. Naarala, Pre-exposure to 50 HZ magnetic fields modifies menadione-induced genotoxic effects in human SH-SY5Y neuroblastoma cells, PLoS One 6(3) (2011), doi: 10.1371\/journal.pone.0018021.","DOI":"10.1371\/journal.pone.0018021"},{"key":"10.1016\/j.bioelechem.2022.108196_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrgentox.2015.10.004","article-title":"Genomic instability induced by 50Hz magnetic fields is a dynamically evolving process not blocked by antioxidant treatment","volume":"794","author":"Kesari","year":"2015","journal-title":"Mutat. Res. - Genet. Toxicol. Environ. Mutagen."},{"issue":"6","key":"10.1016\/j.bioelechem.2022.108196_b0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/09553002.2017.1294275","article-title":"Cellular detection of 50 Hz magnetic fields and weak blue light: effects on superoxide levels and genotoxicity","volume":"93","author":"H\u00f6yt\u00f6","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108196_b0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/bem.20625","article-title":"Effects of a moderate-intensity static magnetic field and adriamycin on K562 cells","volume":"32","author":"Hao","year":"2011","journal-title":"Bioelectromagnetics"},{"issue":"8","key":"10.1016\/j.bioelechem.2022.108196_b0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/bem.21732","article-title":"Short-term exposure to 50Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells","volume":"33","author":"Buldak","year":"2012","journal-title":"Bioelectromagnetics"},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00232-013-9605-0","article-title":"The effect of ELF magnetic field on tumor growth after electrochemotherapy","volume":"247","author":"Mahna","year":"2014","journal-title":"J. Membr. Biol."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19247-8","article-title":"The static magnetic field remotely boosts the efficiency of doxorubicin through modulating ROS Behaviors","volume":"8","author":"Hajipour Verdom","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioelechem.2022.108196_b0075","unstructured":"L. Brunton, B. Chabner, B. Knollman, Goodman and Gilman\u2019s, The Pharmacological Basis of Therapeutics, vol. 12th editi. 2011."},{"issue":"1","key":"10.1016\/j.bioelechem.2022.108196_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5939-z","article-title":"Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model","volume":"19","author":"Christowitz","year":"2019","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.bioelechem.2022.108196_b0085","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.lfs.2004.05.040","article-title":"Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide","volume":"76","author":"Mizutani","year":"2005","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bioelechem.2022.108196_b0090","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bcp.2012.03.010","article-title":"Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination","volume":"83","author":"Luanpitpong","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioelechem.2022.108196_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9474823","article-title":"Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells","volume":"2019","author":"Doroshow","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.bioelechem.2022.108196_b0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108196_b0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/09553000802360836","article-title":"Pre-exposure to 50 Hz magnetic fields modifies menadione-induced DNA damage response in murine L929 cells","volume":"84","author":"Markkanen","year":"2008","journal-title":"Int. J. Radiat. Biol."},{"issue":"May","key":"10.1016\/j.bioelechem.2022.108196_b0110","article-title":"The duration of exposure to 50 Hz magnetic fields: Influence on circadian genes and DNA damage responses in murine hematopoietic FDC-P1 cells","volume":"823","author":"Mustafa","year":"2021","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.bioelechem.2022.108196_b0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-4939-7598-3_32","article-title":"Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK Knockout Mice Blood Vessels","volume":"1732","author":"Wang","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.bioelechem.2022.108196_b0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"issue":"5","key":"10.1016\/j.bioelechem.2022.108196_b0125","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"issue":"SEP","key":"10.1016\/j.bioelechem.2022.108196_b0130","first-page":"1","article-title":"Grouping of experimental conditions as an approach to evaluate effects of extremely low-frequency magnetic fields on oxidative response in in vitro studies","volume":"2","author":"Mattsson","year":"2014","journal-title":"Front. Public Heal."},{"issue":"10","key":"10.1016\/j.bioelechem.2022.108196_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18102175","article-title":"Magnetic fields and reactive oxygen species","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioelechem.2022.108196_b0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopha.2017.05.050","article-title":"Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz, 100 G)","volume":"92","author":"Akbarnejad","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"C","key":"10.1016\/j.bioelechem.2022.108196_b0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82\u201383","author":"Winterbourn","year":"1995","journal-title":"Toxicol. Lett."},{"issue":"24","key":"10.1016\/j.bioelechem.2022.108196_b0150","doi-asserted-by":"crossref","first-page":"13635","DOI":"10.1073\/pnas.93.24.13635","article-title":"Superoxide accelerates DNA damage by elevating free-iron levels","volume":"93","author":"Keyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioelechem.2022.108196_b0155","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2007"},{"key":"10.1016\/j.bioelechem.2022.108196_b0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2014.02.028","article-title":"Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications","volume":"66","author":"Agudelo","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.bioelechem.2022.108196_b0165","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","article-title":"Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death","volume":"66","author":"Swift","year":"2006","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.bioelechem.2022.108196_b0170","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"July","key":"10.1016\/j.bioelechem.2022.108196_b0175","first-page":"1","article-title":"Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device","volume":"11","author":"Baskin","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Bioelectrochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567539422001475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567539422001475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:56:30Z","timestamp":1761584190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567539422001475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"alternative-id":["S1567539422001475"],"URL":"https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108196","relation":{},"ISSN":["1567-5394"],"issn-type":[{"value":"1567-5394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Static or 50\u00a0Hz magnetic fields at 100 \u00b5T do not modify the clonogenic survival of doxorubicin-treated MCF-7 cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioelectrochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108196"}}